腹膜后与经腹腔机器人辅助肾部分切除术的多中心比较
腹膜后组住院时间中位数1.0天 vs 经腹腔组3.0天(P<.001),出血量100 mL vs 125 mL(P=.007),其余手术及围手术期结局无差异。
要点
- 腹膜后入路住院时间更短(中位1.0天 vs 3.0天,P<.001)
- 腹膜后入路出血量更少(中位100 mL vs 125 mL,P=.007)
- 两种入路手术时间、热缺血时间、并发症及切缘阳性率无差异
核心结论
- 在多中心环境下,腹膜后与经腹腔机器人辅助肾部分切除术的手术及围手术期结局相当,仅腹膜后入路住院时间更短。
研究设计与样本
- Vattikuti集体质量倡议前瞻性数据库2014至2018年的事后分析。
- 采用逆概率治疗加权调整年龄、性别、体重指数、合并症、手术侧别、肿瘤位置/大小/复杂度、肾功能、ASA评分及手术年份等选择偏倚。
主要发现
- 腹膜后组99例,经腹腔组394例。
- 住院时间中位数:经腹腔组3.0天(IQR 2.0-4.0),腹膜后组1.0天(IQR 1.0-3.0),P<.001。
- 出血量中位数:经腹腔组125 mL(IQR 50-250),腹膜后组100 mL(IQR 50-150),P=.007。
- 手术时间(P=.6)、热缺血时间(P=.6)、术中并发症(P=.99)、根治性肾切除转换(P=.6)、术后主要并发症(P=.6)、切缘阳性(P=.95)及估算肾小球滤过率下降(P=.7)均无差异。
临床怎么用
- 腹膜后入路可作为机器人辅助肾部分切除术的合理选择,尤其适合期望缩短住院时间的患者。
- 两种入路在肿瘤学及肾功能结局方面相当,术式选择可基于肿瘤特征和术者经验个体化决定。
局限性
- 为事后分析,可能存在未测量的混杂因素。
- 排除未开展腹膜后入路的中心患者,可能引入选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate retroperitoneal robot-assisted partial nephrectomy (RAPN) against transperitoneal approach in a multi-institutional prospective database, after accounting for potential selection bias that may affect this comparison. PATIENTS AND METHODS: Post-hoc analysis of the prospective arm of the Vattikuti Collective Quality Initiative database from 2014 to 2018. Six hundred and ninety consecutive patients underwent RAPN by 22 surgeons at 14 centers in 9 countries. Patients who had surgery at centers not performing retroperitoneal approach (n = 197) were excluded. Inverse probability of treatment weighting was done to account for potential selection bias by adjusting for age, gender, body mass index, comorbidities, side of surgery, location/size/complexity of tumor, renal function, American Society of Anesthesiologists score, and year of surgery. Operative and perioperative outcomes were compared between weighted transperitoneal and retroperitoneal cohorts. RESULTS: Ninety-nine patients underwent retroperitoneal RAPN; 394 underwent transperitoneal RAPN. Hospital stay in days-median 3.0 (Interquartile range [IQR] 2.0-4.0) transperitoneal vs 1.0 (1.0-3.0) retroperitoneal; P < .001, and blood loss in mL-125 (50-250) transperitoneal vs 100 (50-150) retroperitoneal; P = .007-were lower in the retroperitoneal group. There were no differences in operative time (P = .6), warm ischemia time (P = .6), intraoperative complications (P = .99), conversion to radical nephrectomy (P = .6), postoperative major complications (P = .6), positive surgical margins (P = .95), or drop in estimated glomerular filtration rate (P = .7). CONCLUSION: In a multi-institutional setting, both retroperitoneal and transperitoneal approach to RAPN have comparable operative and perioperative outcomes, except for shorter hospital stay with the retroperitoneal approach.
引用
- Arora S, Heulitt G, Menon M, et al. Retroperitoneal vs Transperitoneal Robot-assisted Partial Nephrectomy: Comparison in a Multi-institutional Setting. Urology. 2018. PMID: 30053396. doi:10.1016/j.urology.2018.06.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。